Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If you need an accessible version of this item please contact JSTOR User Support

Prenatal Immunotoxicant Exposure and Postnatal Autoimmune Disease

Steven D. Holladay
Environmental Health Perspectives
Vol. 107, Supplement 5: Linking Environmental Agents to Autoimmune Diseases (Oct., 1999), pp. 687-691
DOI: 10.2307/3434328
Stable URL: http://www.jstor.org/stable/3434328
Page Count: 5
  • Read Online (Free)
  • Cite this Item
If you need an accessible version of this item please contact JSTOR User Support
Prenatal Immunotoxicant Exposure and Postnatal Autoimmune Disease
Preview not available

Abstract

Reports in humans and rodents indicate that immune development may be altered following perinatal exposure to immunotoxic compounds, including chemotherapeutics, corticosteroids, polycyclic hydrocarbons, and polyhalogenated hydrocarbons. Effects from such exposure may be more dramatic or persistent than following exposure during adult life. For example, prenatal exposure to the insecticide chlordane or to the polycyclic aromatic hydrocarbon benzo[a]pyrene produces what appears to be lifelong immunosuppression in mice. Whether prenatal immunotoxicant exposure may predispose the organism to postnatal autoimmune disease remains largely unknown. In this regard, the therapeutic immunosuppressant cyclosporin A (CsA) crosses the placenta poorly. However, lethally irradiated rodents exposed to CsA postsyngeneic bone marrow transplant (i.e., during re-establishment of the immune system) develop T-cell-mediated autoimmune disease, suggesting this drug may produce a fundamental disruption in development of self-tolerance by T cells. The environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) crosses the placenta and produces fetal thymic effects in vivo similar to effects of CsA in fetal thymic organ culture, including inhibited thymocyte maturation and reduced expression of thymic major histocompatability complex class II molecules. These observations led to the suggestion that gestational exposure to TCDD may interfere with normal development of self-tolerance. Possibly supporting this hypothesis, when mice predisposed to development of autoimmune disease were treated with TCDD during gestation, postnatal autoimmunity was exacerbated. Similar results have been reported for mice exposed to diethylstilbestrol during development. These reports suggest that prenatal exposure to certain immunotoxicants may play a role in postnatal expression of autoimmunity.

Page Thumbnails

  • Thumbnail: Page 
687
    687
  • Thumbnail: Page 
688
    688
  • Thumbnail: Page 
689
    689
  • Thumbnail: Page 
690
    690
  • Thumbnail: Page 
691
    691